KATELYN DVORSKY: Open Payments
NPI 1093188831 · WACO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$788 in 40 payments from 14 companies in 2025. Trend: 2023 $976 · 2024 $927 · 2025 $788
Food & beverage: $778Education: $10
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $160 |
| Amgen Inc. | 4 | $92 |
| GENZYME CORPORATION | 3 | $78 |
| Regeneron Healthcare Solutions, Inc. | 3 | $74 |
| UCB, Inc. | 3 | $63 |
| Galderma Laboratories, L.P. | 3 | $57 |
| Janssen Biotech, Inc. | 2 | $52 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $39 |
| Incyte Corporation | 2 | $39 |
| PFIZER INC. | 2 | $33 |
Products named: DUPIXENT, OTEZLA, SKYRIZI, RINVOQ, Bimzelx, NEMLUVIO, TREMFYA, ILUMYA.
Industry payments across TX — which companies pay providers there.
